Will Spooner, Eagle's CTO will be speaking at The O'Reilly Strata Conference in London on 1st -2nd October. O'Reilly Strata is a conference which brings together the best minds in data to explore the opportunities made possible by the latest state-of-the-art big data tools and analytic approaches.
The event includes many other exciting talks about coding challenges and dealing with big data in multiple industry sectors, with the speaker list including several big names such as Google, Tesco, Amazon, and the New York Times.
Will's talk is about big (sequence) data in pre-competitive pharmaceutical R&D.
One of the grand-challenges in healthcare today is the development of truly personalised medicine. It is recognised that, whilst pushing the limits of current information technology, the development of such tools in-house provides little competetive advantage for companies engaged in pharmaceutical R&D. Once a particular technological challenge has been identified as pre-competitive it frees the stakeholders to collaborate on the specification and share the costs of developing a solution. The Pistoia Alliance Sequence Services project (of which Eagle is a member) is a great example of this approach with demonstrable benefits for solution "seekers" and "solvers" alike.
Will is a strong supporter of this method of addressing pre-competitive problems and encourages others to consider whether similar collaborative approaches could be applied to solving their particular big data challenge.
Will's presentation will go through the science, logistics, regulations and integration of solutions that use this approach. Follow him on @wspoonr to ask questions and learn more.